We present a case of a 74-year-old patient with schizoaffective disorder, who developed risperidone-related neurleptic malignant syndrome. This patient responded satisfactorily to the supportive management and vit E plus vit B6.
Adler L., Peselow E., Rotrosen J., Duncan E., Lee M., Rosenthal M., Angrist B. (1993) Vitamin E treatment of tardive dyskinesia. Am J Psychiat150:1405-1407
2.
Akhtar S., Jajor TR, Kumar S. (1993) Vitamin E in the treatment of tardive dyskinesia . J Postgrad Med39: 124-126
3.
American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 3rd edn, revised (DSM-IV). American Psychiatric Association , Washington, DC
4.
Caroff S.J., Mann S.C., Lazarus A., Sullivan K., MacFadden W. (1991) Neuroleptic malignant syndrome: diagnostic issues . Psychiat Ann21:130-147
5.
Coupland N., Nutt D. ( 1995) Successful treatment of tardive oculogyric spasms with vitamin E. J Clin Psychopharmac15: 285-286
6.
Dabiri L.M., Pasta D., DarbyJ.K., Mosbacher D. (1994) Effectiveness of vitamin E in the treatment of long-term tardive dyskinesia: a replication study. Am J Psychiat151: 925-926
7.
Egan M.F., Hyde T.M., Albers G.W., Elkashef A., Alexander R.C., Reeve A., Blum A., Saenz R.E., Wyatt R.J. (1992) Treatment of tardive dyskinesia with vitamin E . Am J Psychiat149: 773-777
8.
Gattaz W.F., Emrich A., Behrens S. (1992) Vitamin E attenuates the development of neuroleptic- induced dopaminergic hypersensitivity in rats: implications for tardive dyskinesia . Clin Neuropharmac15: 267B
Jeste D.V., Lohr J.B., Clarke K., Wyatt R.J. (1988) Pharmacological treatments of tardive dyskinesia in the 1980s. J Clin Psychopharmac8: 38S-48S
11.
Lee H., Ryan J., Mullett G., Lawlor B.A. (1994) Neuroleptic malignant syndrome associated with the use of risperidone, an atypical antipsychotic agent. Hum Psychopharmac9: 303-305
12.
Lohr J., Caligiuri M. (1996) A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia. J Clin Psychiat57: 167-173
13.
Lohr J.B., Kuczenski R., Bracha H.S., Moir M., Wyatt R.J., Jeste D.V. (1990) Increased indices of free radical-activity in the cerebrospinal fluid of patients with tardive dyskinesia. Biol Psychiat28: 535-539
14.
Muller T., Becker T., Fritzc J. (1988) Neuroleptic malignant syndrome after clozapine plus carbamazepine. Lancet31:1500
15.
Szymanski S., Maune R., Gordon M.F., Lieberman J. (1993) A selective review of recent advances in the management of tardive dyskinesia. Psychiat Ann23: 209-215
